Risk factors for the development of endometrial lesions in breast cancer patients using tamoxyphen: a retrospective cohort study.
Alvo Orlando VizzottoSergio Mancini NicolauGuilherme Munhoz LopesAdauto Castelo FilhoPublished in: Revista do Colegio Brasileiro de Cirurgioes (2023)
furthermore, the association between tamofixen and endometrial changes remained significant (p=0.039) after adjusting for obesity.